Genmab Announces Changes to its Executive Committee

Core Points - Genmab A/S announced the retirement of Birgitte Stephensen, Executive Vice President and Chief Legal Officer, after 23 years with the company, effective July 1, 2025 [1][2] - Greg Mueller has been appointed as the new Executive Vice President, General Counsel, and Chief Legal Officer, effective July 1, 2025, and will report to the President and CEO, Dr. Jan van de Winkel [1][3] Company Overview - Genmab is an international biotechnology company focused on improving patient lives through innovative antibody therapeutics, with a vision to transform the lives of people with cancer and other serious diseases by 2030 [5] - Established in 1999 and headquartered in Copenhagen, Denmark, Genmab has a global presence across North America, Europe, and Asia Pacific [6]